nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced Drug Delivery Reviews: Advancing science, improving therapy
|
Lee, Vincent H.L. |
|
2011 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
2 |
Affinity reagents against tumour-associated extracellular molecules and newforming vessels
|
Neri, Dario |
|
1998 |
149-150 |
1-2 |
p. 43-52 10 p. |
artikel |
3 |
An antigenomic strategy for treating heteroplasmic mtDNA disorders
|
Taylor, Robert W. |
|
2001 |
149-150 |
1-2 |
p. 121-125 5 p. |
artikel |
4 |
Anatomy, physiology and function of the nasal cavities in health and disease
|
Mygind, Niels |
|
1998 |
149-150 |
1-2 |
p. 3-12 10 p. |
artikel |
5 |
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
|
Nordskog, Brian K. |
|
2001 |
149-150 |
1-2 |
p. 21-44 24 p. |
artikel |
6 |
Animal models for the study of intestinal lymphatic drug transport
|
Edwards, Glenn A |
|
2001 |
149-150 |
1-2 |
p. 45-60 16 p. |
artikel |
7 |
Announcement
|
|
|
1990 |
149-150 |
1-2 |
p. v- 1 p. |
artikel |
8 |
Antibodies for targeted gene therapy: extracellular gene targeting and intracellular expression
|
Dana Jones, Susan |
|
1998 |
149-150 |
1-2 |
p. 153-170 18 p. |
artikel |
9 |
Anticancer therapy using glucuronate modified long-circulating liposomes
|
Oku, Naoto |
|
1999 |
149-150 |
1-2 |
p. 63-73 11 p. |
artikel |
10 |
Biodegradable hydrogels in drug delivery
|
Kamath, Kalpana R. |
|
1993 |
149-150 |
1-2 |
p. 59-84 26 p. |
artikel |
11 |
Biomechanics of cell interactions in shear fields
|
Konstantopoulos, Konstantinos |
|
1998 |
149-150 |
1-2 |
p. 141-164 24 p. |
artikel |
12 |
Biophysical kinetic modeling of buccal absorption
|
Ho, N.F.H. |
|
1993 |
149-150 |
1-2 |
p. 61-97 37 p. |
artikel |
13 |
Bispecific antibodies for treatment of cancer in experimental animal models and man
|
Kroesen, B.J |
|
1998 |
149-150 |
1-2 |
p. 105-129 25 p. |
artikel |
14 |
Buccal delivery systems using hydrogels
|
Nagai, Tsuneji |
|
1993 |
149-150 |
1-2 |
p. 179-191 13 p. |
artikel |
15 |
Caco-2 monolayers in experimental and theoretical predictions of drug transport
|
Artursson, Per |
|
1996 |
149-150 |
1-2 |
p. 67-84 18 p. |
artikel |
16 |
Carrier-mediated transport and efflux mechanisms in Caco-2 cells
|
Hidalgo, Ismael J. |
|
1996 |
149-150 |
1-2 |
p. 53-66 14 p. |
artikel |
17 |
Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems
|
Weissig, Volkmar |
|
2001 |
149-150 |
1-2 |
p. 127-149 23 p. |
artikel |
18 |
Cell-based tissue engineering therapies: the influence of whole body physiology.
|
Haynesworth, Stephen E. |
|
1998 |
149-150 |
1-2 |
p. 3-14 12 p. |
artikel |
19 |
Cell delivery to the central nervous system
|
Shoichet, Molly S |
|
2000 |
149-150 |
1-2 |
p. 81-102 22 p. |
artikel |
20 |
Cells for drug delivery platforms
|
Han Bae, You |
|
2000 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
21 |
Cell transplantation for endocrine disorders
|
Lee, Moon-Kyu |
|
2000 |
149-150 |
1-2 |
p. 103-120 18 p. |
artikel |
22 |
Cellular transplants as sources for therapeutic agents
|
Tresco, Patrick A. |
|
2000 |
149-150 |
1-2 |
p. 3-27 25 p. |
artikel |
23 |
Challenges in inhaled product development and opportunities for open innovation
|
Forbes, Ben |
|
2011 |
149-150 |
1-2 |
p. 69-87 19 p. |
artikel |
24 |
Chemical targeting of drug therapy in asthma and airways disease
|
Seale, J.Paul |
|
1990 |
149-150 |
1-2 |
p. 73-92 20 p. |
artikel |
25 |
Chewing gum as a drug delivery system
|
Rømer Rassing, Margrethe |
|
1994 |
149-150 |
1-2 |
p. 89-121 33 p. |
artikel |
26 |
Clearance properties of liposomes involving conjugated proteins for targeting
|
Harasym, Troy O. |
|
1998 |
149-150 |
1-2 |
p. 99-118 20 p. |
artikel |
27 |
Controlling liposome blood clearance by surface-grafted polymers
|
Woodle, Martin C |
|
1998 |
149-150 |
1-2 |
p. 139-152 14 p. |
artikel |
28 |
Creating and engineering human antibodies for immunotherapy
|
de Haard, Hans |
|
1998 |
149-150 |
1-2 |
p. 5-31 27 p. |
artikel |
29 |
Culture of organized cell communities
|
Freed, Lisa E |
|
1998 |
149-150 |
1-2 |
p. 15-30 16 p. |
artikel |
30 |
Delivery of antifungal agents to the oral cavity
|
Samaranayake, Lakshman P. |
|
1994 |
149-150 |
1-2 |
p. 161-179 19 p. |
artikel |
31 |
Delivery systems for the administration of drugs to the periodontal pocket
|
Medlicott, Natalie J. |
|
1994 |
149-150 |
1-2 |
p. 181-203 23 p. |
artikel |
32 |
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
|
Modica-Napolitano, Josephine S |
|
2001 |
149-150 |
1-2 |
p. 63-70 8 p. |
artikel |
33 |
Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung
|
Byron, Peter R. |
|
1990 |
149-150 |
1-2 |
p. 107-132 26 p. |
artikel |
34 |
Development of engineered cells for implantation in gene therapy
|
Chang, Patricia L. |
|
1998 |
149-150 |
1-2 |
p. 31-43 13 p. |
artikel |
35 |
Development of engineered pancreatic β-cell lines for cell therapy of diabetes
|
Efrat, Shimon |
|
1998 |
149-150 |
1-2 |
p. 45-52 8 p. |
artikel |
36 |
Development of intestinal cell culture models for drug transport and metabolism studies
|
Quaroni, A. |
|
1996 |
149-150 |
1-2 |
p. 3-52 50 p. |
artikel |
37 |
Drug and DNA delivery to mitochondria
|
|
|
2001 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
38 |
Drug delivery strategies in malignant disease of the lung
|
Willmott, N. |
|
1990 |
149-150 |
1-2 |
p. 133-148 16 p. |
artikel |
39 |
Drug metabolism in the oral cavity
|
Yamahara, Hiroshi |
|
1993 |
149-150 |
1-2 |
p. 25-39 15 p. |
artikel |
40 |
Editorial
|
|
|
1998 |
149-150 |
1-2 |
p. 1- 1 p. |
artikel |
41 |
Editorial
|
|
|
1998 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
42 |
Editorial Board
|
|
|
1996 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
43 |
Editorial Board
|
|
|
1993 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
44 |
Editorial Board
|
|
|
1994 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
45 |
Editorial Board
|
|
|
2011 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
46 |
Editorial Board
|
|
|
1993 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
47 |
Editorial Board
|
|
|
1990 |
149-150 |
1-2 |
p. ii- 1 p. |
artikel |
48 |
Effects of physicochemical properties and other factors on systemic nasal drug delivery
|
Behl, C.R |
|
1998 |
149-150 |
1-2 |
p. 89-116 28 p. |
artikel |
49 |
Endothelial cell delivery for cardiovascular therapy
|
Parikh, Sahil A |
|
2000 |
149-150 |
1-2 |
p. 139-161 23 p. |
artikel |
50 |
Exploiting M cells for drug and vaccine delivery
|
Clark, M.Ann |
|
2001 |
149-150 |
1-2 |
p. 81-106 26 p. |
artikel |
51 |
Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials
|
Ponchel, Gilles |
|
1994 |
149-150 |
1-2 |
p. 75-87 13 p. |
artikel |
52 |
Forthcoming articles
|
|
|
1994 |
149-150 |
1-2 |
p. 205-206 2 p. |
artikel |
53 |
Forthcoming articles
|
|
|
1993 |
149-150 |
1-2 |
p. 193-195 3 p. |
artikel |
54 |
Forthcoming articles
|
|
|
1993 |
149-150 |
1-2 |
p. 127-128 2 p. |
artikel |
55 |
Forthcoming events
|
|
|
1993 |
149-150 |
1-2 |
p. 129-130 2 p. |
artikel |
56 |
Forthcoming events
|
|
|
1994 |
149-150 |
1-2 |
p. 207-208 2 p. |
artikel |
57 |
Forthcoming events
|
|
|
1993 |
149-150 |
1-2 |
p. 197-199 3 p. |
artikel |
58 |
Gene therapy approaches for modulating bone regeneration
|
Winn, Shelley R |
|
2000 |
149-150 |
1-2 |
p. 121-138 18 p. |
artikel |
59 |
Gene therapy by mitochondrial transfer
|
Kagawa, Yasuo |
|
2001 |
149-150 |
1-2 |
p. 107-119 13 p. |
artikel |
60 |
Gene therapy for tissue repair and regeneration
|
Bonadio, Jeffrey |
|
1998 |
149-150 |
1-2 |
p. 53-69 17 p. |
artikel |
61 |
Host response to tissue engineered devices
|
Babensee, Julia E. |
|
1998 |
149-150 |
1-2 |
p. 111-139 29 p. |
artikel |
62 |
Human mitochondrial DNA diseases
|
Pulkes, T |
|
2001 |
149-150 |
1-2 |
p. 27-43 17 p. |
artikel |
63 |
Hydrogel delivery systems based on polymer blends, block co-polymers or interpenetrating networks
|
Bae, You Han |
|
1993 |
149-150 |
1-2 |
p. 109-135 27 p. |
artikel |
64 |
Hydrogel delivery systems for vaginal and oral applications
|
Knuth, Kim |
|
1993 |
149-150 |
1-2 |
p. 137-167 31 p. |
artikel |
65 |
Identification of proteins mediating clearance of liposomes using a liver perfusion system
|
Harashima, H |
|
1998 |
149-150 |
1-2 |
p. 61-79 19 p. |
artikel |
66 |
Immunocompatibility and biocompatibility of cell delivery systems
|
Řı́hová, Blanka |
|
2000 |
149-150 |
1-2 |
p. 65-80 16 p. |
artikel |
67 |
Immunoliposomes for the targeted delivery of antitumor drugs
|
Mastrobattista, Enrico |
|
1999 |
149-150 |
1-2 |
p. 103-127 25 p. |
artikel |
68 |
Immunotoxins for targeted cancer therapy
|
Kreitman, Robert J |
|
1998 |
149-150 |
1-2 |
p. 53-88 36 p. |
artikel |
69 |
Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo
|
Semple, Sean C |
|
1998 |
149-150 |
1-2 |
p. 3-17 15 p. |
artikel |
70 |
Intestinal lymphatic drug transport: an update
|
Porter, Christopher J.H. |
|
2001 |
149-150 |
1-2 |
p. 61-80 20 p. |
artikel |
71 |
Intranasal drug delivery
|
Hussain, Anwar A |
|
1998 |
149-150 |
1-2 |
p. 39-49 11 p. |
artikel |
72 |
Intravital microscopy as a tool to study drug delivery in preclinical studies
|
Amornphimoltham, Panomwat |
|
2011 |
149-150 |
1-2 |
p. 119-128 10 p. |
artikel |
73 |
In vitro cell models to study nasal mucosal permeability and metabolism
|
Schmidt, M.Christiane |
|
1998 |
149-150 |
1-2 |
p. 51-79 29 p. |
artikel |
74 |
Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption
|
Donovan, Maureen D |
|
1998 |
149-150 |
1-2 |
p. 147-155 9 p. |
artikel |
75 |
Liposomes as drug delivery systems to the lung
|
Kellaway, Ian W. |
|
1990 |
149-150 |
1-2 |
p. 149-161 13 p. |
artikel |
76 |
Liposomes to target the lymphatics by subcutaneous administration
|
Oussoren, Christien |
|
2001 |
149-150 |
1-2 |
p. 143-156 14 p. |
artikel |
77 |
Local delivery of antimicrobial agents to the oral cavity
|
Addy, Martin |
|
1994 |
149-150 |
1-2 |
p. 123-134 12 p. |
artikel |
78 |
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
|
Porter, C.J.H |
|
2001 |
149-150 |
1-2 |
p. 157-171 15 p. |
artikel |
79 |
Man-made superantigens: Tumor-selective agents for T-cell-based therapy
|
Brodin, Thomas N |
|
1998 |
149-150 |
1-2 |
p. 131-142 12 p. |
artikel |
80 |
Materials for immunoisolated cell transplantation
|
Li, Rebecca H |
|
1998 |
149-150 |
1-2 |
p. 87-109 23 p. |
artikel |
81 |
Materials for protein delivery in tissue engineering
|
Baldwin, Samuel P |
|
1998 |
149-150 |
1-2 |
p. 71-86 16 p. |
artikel |
82 |
Mathematical modeling of deposition and disposition of drugs administered via the nose
|
Gonda, Igor |
|
1998 |
149-150 |
1-2 |
p. 179-184 6 p. |
artikel |
83 |
Mechanisms and kinetics of liposome–cell interactions
|
Düzgüneş, Nejat |
|
1999 |
149-150 |
1-2 |
p. 3-18 16 p. |
artikel |
84 |
Mechanisms, barriers and pathways of oral mucosal drug permeation
|
Rathbone, Michael J. |
|
1993 |
149-150 |
1-2 |
p. 41-60 20 p. |
artikel |
85 |
Methods for assessing the buccal mucosa as a route of drug delivery
|
Janet Hoogstraate, A. |
|
1993 |
149-150 |
1-2 |
p. 99-125 27 p. |
artikel |
86 |
Microspheres as nasal drug delivery systems
|
Pereswetoff-Morath, Lena |
|
1998 |
149-150 |
1-2 |
p. 185-194 10 p. |
artikel |
87 |
Mitochondria as subcellular targets for clinically useful anthracyclines
|
Jung, Katinka |
|
2001 |
149-150 |
1-2 |
p. 87-105 19 p. |
artikel |
88 |
Mitochondria as target for antiischemic drugs
|
Morin, Didier |
|
2001 |
149-150 |
1-2 |
p. 151-174 24 p. |
artikel |
89 |
Mitochondria-based photodynamic anti-cancer therapy
|
Morgan, Janet |
|
2001 |
149-150 |
1-2 |
p. 71-86 16 p. |
artikel |
90 |
Mitochondrial contributions to cancer cell physiology: potential for drug development
|
Preston, Thomas J |
|
2001 |
149-150 |
1-2 |
p. 45-61 17 p. |
artikel |
91 |
Mitochondrial DNA metabolism targeting drugs
|
Rowe, Thomas C |
|
2001 |
149-150 |
1-2 |
p. 175-187 13 p. |
artikel |
92 |
Mitochondria make a come back
|
Scheffler, Immo E. |
|
2001 |
149-150 |
1-2 |
p. 3-26 24 p. |
artikel |
93 |
Mucus and mucociliary clearance in the respiratory tract
|
Marriott, C. |
|
1990 |
149-150 |
1-2 |
p. 19-35 17 p. |
artikel |
94 |
Nasal delivery systems and their effect on deposition and absorption
|
Kublik, H |
|
1998 |
149-150 |
1-2 |
p. 157-177 21 p. |
artikel |
95 |
Nasal mucociliary clearance as a factor in nasal drug delivery
|
Marttin, Emmeline |
|
1998 |
149-150 |
1-2 |
p. 13-38 26 p. |
artikel |
96 |
Novel vaginal drug release applications
|
Brannon-Peppas, Lisa |
|
1993 |
149-150 |
1-2 |
p. 169-177 9 p. |
artikel |
97 |
Optimization of systemic nasal drug delivery with pharmaceutical excipients
|
Behl, C.R |
|
1998 |
149-150 |
1-2 |
p. 117-133 17 p. |
artikel |
98 |
Oral cavity as a site for bioadhesive drug delivery
|
Gandhi, Rajesh B. |
|
1994 |
149-150 |
1-2 |
p. 43-74 32 p. |
artikel |
99 |
Overview of clinical trials employing antibody-targeted superantigens
|
Alpaugh, R.Katherine |
|
1998 |
149-150 |
1-2 |
p. 143-152 10 p. |
artikel |
100 |
Peptide hormones: Review of current and emerging uses by nasal delivery
|
Pontiroli, Antonio E |
|
1998 |
149-150 |
1-2 |
p. 81-87 7 p. |
artikel |
101 |
Permeability and the pathophysiology of oral mucosa
|
Squier, Christopher A. |
|
1993 |
149-150 |
1-2 |
p. 13-24 12 p. |
artikel |
102 |
Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes
|
Harashima, H. |
|
1999 |
149-150 |
1-2 |
p. 39-61 23 p. |
artikel |
103 |
Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors
|
Nishikawa, Makiya |
|
1999 |
149-150 |
1-2 |
p. 19-37 19 p. |
artikel |
104 |
Possibility of active targeting to tumor tissues with liposomes
|
Maruyama, Kazuo |
|
1999 |
149-150 |
1-2 |
p. 89-102 14 p. |
artikel |
105 |
Preface
|
Dohlsten, Mikael |
|
1998 |
149-150 |
1-2 |
p. 1-3 3 p. |
artikel |
106 |
Preface
|
Hochman, Jerome H. |
|
1996 |
149-150 |
1-2 |
p. 1- 1 p. |
artikel |
107 |
Preface
|
Rathbone, M.J. |
|
1993 |
149-150 |
1-2 |
p. vii-viii nvt p. |
artikel |
108 |
Preface
|
Scranton, Alec B. |
|
1993 |
149-150 |
1-2 |
p. vii-viii nvt p. |
artikel |
109 |
Preface
|
Rathbone, M.J. |
|
1994 |
149-150 |
1-2 |
p. v-vi nvt p. |
artikel |
110 |
Preface
|
Mitra, Ashim K |
|
1998 |
149-150 |
1-2 |
p. 1- 1 p. |
artikel |
111 |
Preface. Major issues and future prospects in the delivery of therapeutic and diagnostic agents to the respiratory tract
|
Gonda, Igor |
|
1990 |
149-150 |
1-2 |
p. 1-9 9 p. |
artikel |
112 |
Preparation, structure and diffusional behavior of hydrogels in controlled release
|
Peppas, Nikolaos A. |
|
1993 |
149-150 |
1-2 |
p. 1-35 35 p. |
artikel |
113 |
Problems and opportunities in the topical treatment of infectious diseases of the respiratory tract
|
Ilowite, Jonathan S. |
|
1990 |
149-150 |
1-2 |
p. 93-105 13 p. |
artikel |
114 |
Prodrug-based intracellular delivery of anticancer agents
|
Bildstein, L. |
|
2011 |
149-150 |
1-2 |
p. 3-23 21 p. |
artikel |
115 |
Prodrugs for nasal drug delivery
|
Krishnamoorthy, Ramesh |
|
1998 |
149-150 |
1-2 |
p. 135-146 12 p. |
artikel |
116 |
Production and selection of antigen-specific fully human monoclonal antibodies from mice engineered with human Ig loci
|
Jakobovits, Aya |
|
1998 |
149-150 |
1-2 |
p. 33-42 10 p. |
artikel |
117 |
Pulsatile drug delivery systems using hydrogels
|
Yoshida, Ryo |
|
1993 |
149-150 |
1-2 |
p. 85-108 24 p. |
artikel |
118 |
Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics
|
Hussain, Nasir |
|
2001 |
149-150 |
1-2 |
p. 107-142 36 p. |
artikel |
119 |
Receptor versus non-receptor mediated clearance of liposomes
|
Scherphof, Gerrit L |
|
1998 |
149-150 |
1-2 |
p. 81-97 17 p. |
artikel |
120 |
Recombinant DNA technology as an investigative tool in drug metabolism research
|
Friedberg, Thomas |
|
1996 |
149-150 |
1-2 |
p. 187-213 27 p. |
artikel |
121 |
Reconstitution of the blood-brain barrier in cell culture for studies of drug transport and metabolism
|
de Boer, A.G. |
|
1996 |
149-150 |
1-2 |
p. 251-264 14 p. |
artikel |
122 |
Regional variation in the structure and permeability of oral mucosa and skin
|
Wertz, Philip W. |
|
1993 |
149-150 |
1-2 |
p. 1-12 12 p. |
artikel |
123 |
Respiratory epithelial cell culture models for evaluation of ion and drug transport
|
Mathias, Neil R. |
|
1996 |
149-150 |
1-2 |
p. 215-249 35 p. |
artikel |
124 |
RNA delivery into mitochondria
|
Entelis, N.S |
|
2001 |
149-150 |
1-2 |
p. 199-215 17 p. |
artikel |
125 |
RNA interference for improving the outcome of islet transplantation
|
Li, Feng |
|
2011 |
149-150 |
1-2 |
p. 47-68 22 p. |
artikel |
126 |
Saliva substitutes in the management of salivary gland dysfunction
|
Ferguson, M.M. |
|
1994 |
149-150 |
1-2 |
p. 151-159 9 p. |
artikel |
127 |
Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system – The concept of tissue specificity
|
Moghimi, S.M |
|
1998 |
149-150 |
1-2 |
p. 45-60 16 p. |
artikel |
128 |
Site-specific differences in the salivary concentrations of substances in the oral cavity — implications for the aetiology of oral disease and local drug delivery
|
Weatherell, John A. |
|
1994 |
149-150 |
1-2 |
p. 23-42 20 p. |
artikel |
129 |
Spatial expression and functionality of drug transporters in the intact lung: Objectives for further research
|
Gumbleton, Mark |
|
2011 |
149-150 |
1-2 |
p. 110-118 9 p. |
artikel |
130 |
Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes
|
LeCluyse, Edward L. |
|
1996 |
149-150 |
1-2 |
p. 133-186 54 p. |
artikel |
131 |
Structural and metabolic consequences of liposome–lipoprotein interactions
|
Rodrigueza, Wendi V |
|
1998 |
149-150 |
1-2 |
p. 31-43 13 p. |
artikel |
132 |
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
|
Mahmoudi, Morteza |
|
2011 |
149-150 |
1-2 |
p. 24-46 23 p. |
artikel |
133 |
Swelling-controlled release in hydrogel matrices for oral route
|
Colombo, Paolo |
|
1993 |
149-150 |
1-2 |
p. 37-57 21 p. |
artikel |
134 |
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
|
Chari, Ravi V.J |
|
1998 |
149-150 |
1-2 |
p. 89-104 16 p. |
artikel |
135 |
Targeting large molecules to mitochondria
|
Muratovska, Aleksandra |
|
2001 |
149-150 |
1-2 |
p. 189-198 10 p. |
artikel |
136 |
Technology of mammalian cell encapsulation
|
Uludag, Hasan |
|
2000 |
149-150 |
1-2 |
p. 29-64 36 p. |
artikel |
137 |
The absorption and metabolism of xenobiotics in the lung
|
Taylor, Glyn |
|
1990 |
149-150 |
1-2 |
p. 37-61 25 p. |
artikel |
138 |
The circulation of the airways: anatomy, physiology and potential role in drug delivery to the respiratory tract
|
Chediak, Alejandro D. |
|
1990 |
149-150 |
1-2 |
p. 11-18 8 p. |
artikel |
139 |
The complement system in liposome clearance: Can complement deposition be inhibited?
|
Devine, Dana V |
|
1998 |
149-150 |
1-2 |
p. 19-29 11 p. |
artikel |
140 |
The handling of inhaled antigen within the respiratory tract
|
Clancy, Robert L. |
|
1990 |
149-150 |
1-2 |
p. 63-72 10 p. |
artikel |
141 |
The oral cavity as a site for systemic drug delivery
|
Rathbone, Michael J. |
|
1994 |
149-150 |
1-2 |
p. 1-22 22 p. |
artikel |
142 |
Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions
|
Papisov, Mikhail I |
|
1998 |
149-150 |
1-2 |
p. 119-138 20 p. |
artikel |
143 |
The Pharmacokinetics of Liposomes in Tumor Targeting
|
Harashima, Hideyoshi |
|
1999 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
144 |
The physiology of the lymphatic system
|
Swartz, Melody A. |
|
2001 |
149-150 |
1-2 |
p. 3-20 18 p. |
artikel |
145 |
The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs
|
Nagayasu, A |
|
1999 |
149-150 |
1-2 |
p. 75-87 13 p. |
artikel |
146 |
The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man
|
Maurel, Patrick |
|
1996 |
149-150 |
1-2 |
p. 105-132 28 p. |
artikel |
147 |
The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development
|
Bailey, Carole A. |
|
1996 |
149-150 |
1-2 |
p. 85-103 19 p. |
artikel |
148 |
Topical corticosteroids and lesions of the oral mucosa
|
Thorburn, Dennis N. |
|
1994 |
149-150 |
1-2 |
p. 135-149 15 p. |
artikel |
149 |
Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment
|
Niven, Ralph W. |
|
2011 |
149-150 |
1-2 |
p. 88-109 22 p. |
artikel |
150 |
Transplantation of cells in matrices for tissue regeneration
|
Marler, Jennifer J |
|
1998 |
149-150 |
1-2 |
p. 165-182 18 p. |
artikel |
151 |
Transport and absorption of drugs via the lymphatic system
|
|
|
2001 |
149-150 |
1-2 |
p. 1-2 2 p. |
artikel |
152 |
Tyrosine kinase chimeras for antigen-selective T-body therapy
|
Fitzer-Attas, Cheryl J |
|
1998 |
149-150 |
1-2 |
p. 171-182 12 p. |
artikel |